CYP19A1 and cancer: Also, resveratrol inhibition of P450/CYP19A1/Aromatase, by limiting the amount of available estrogens and consequently the activity of estrogen receptors, has been proposed to contribute to the protection against several types of cancer, including breast cancer [72, 73].